• Return to Headlines

Amphastar Pharma is Among the Companies in the Pharmaceuticals Industry With the Highest Price to Cash Flow (AMPH, MRK, ZTS, CTLT, ANIP)

By James Quinn

Below are the three companies in the Pharmaceuticals industry with the highest price to cash flow ratios. Often companies with the lowest ratio present the greatest value to investors.

Amphastar Pharma ranks highest with a a price to cash flow ratio of 224.70. Following is Merck & Co with a a price to cash flow ratio of 50.13. Zoetis Inc ranks third highest with a a price to cash flow ratio of 48.66.

Catalent Inc follows with a a price to cash flow ratio of 38.75, and Ani Pharmaceutic rounds out the top five with a a price to cash flow ratio of 28.15.

SmarTrend recommended that subscribers consider buying shares of Ani Pharmaceutic on January 4th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $48.01. Since that recommendation, shares of Ani Pharmaceutic have risen 47.5%. We continue to monitor Ani Pharmaceutic for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest price to cash flow amphastar pharma Merck & Co zoetis inc catalent inc ani pharmaceutic

Ticker(s): AMPH MRK ZTS CTLT ANIP